Back
Also listed as
ESLOF
OTC
Day Range
$110.33
$112.06
52-Week Range
$110.33
$186.81
Volume
9,285
50D / 200D Avg
$142.44
/
$155.10
Prev Close
$112.68
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 46.3 | 0.3 |
| P/B | 2.7 | 2.9 |
| ROE % | 5.6 | 3.7 |
| Net Margin % | 8.1 | 3.8 |
| Rev Growth 5Y % | 8.4 | 10.0 |
| D/E | 0.4 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$5.28
$5.12 – $5.37
|
44 B | 1 |
| FY2029 |
$5.32
$5.16 – $5.41
|
41 B | 1 |
| FY2028 |
$4.82
$4.67 – $4.91
|
38 B | 1 |
Key Takeaways
Revenue grew 8.40% annually over 5 years — modest growth
Debt/Equity of 0.44 — conservative balance sheet
Generating 3.62B in free cash flow
P/E of 46.25 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.16%
Cash machine — converts 162.68% of earnings into free cash flow
Growth
Revenue Growth (5Y)
8.40%
Revenue (1Y)3.24%
Earnings (1Y)-5.74%
FCF Growth (3Y)4.23%
Quality
Return on Equity
5.61%
ROIC4.33%
Net Margin8.13%
Op. Margin11.80%
Safety
Debt / Equity
0.44
Current Ratio0.99
Interest Coverage14.06
Valuation
P/E Ratio
46.25
P/B Ratio2.65
EV/EBITDA36.04
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.24% | Revenue Growth (3Y) | 3.81% |
| Earnings Growth (1Y) | -5.74% | Earnings Growth (3Y) | -1.44% |
| Revenue Growth (5Y) | 8.40% | Earnings Growth (5Y) | 11.32% |
| Profitability | |||
| Revenue (TTM) | 27.37B | Net Income (TTM) | 2.22B |
| ROE | 5.61% | ROA | 3.48% |
| Gross Margin | 60.56% | Operating Margin | 11.80% |
| Net Margin | 8.13% | Free Cash Flow (TTM) | 3.62B |
| ROIC | 4.33% | FCF Growth (3Y) | 4.23% |
| Safety | |||
| Debt / Equity | 0.44 | Current Ratio | 0.99 |
| Interest Coverage | 14.06 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 46.25 | P/B Ratio | 2.65 |
| P/S Ratio | 3.76 | PEG Ratio | -8.27 |
| EV/EBITDA | 36.04 | Dividend Yield | 0.00% |
| Market Cap | 102.84B | Enterprise Value | 116.34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 27.37B | 26.51B | 25.40B | 24.49B | 19.82B |
| Net Income | 2.22B | 2.36B | 2.29B | 2.15B | 1.45B |
| EPS (Diluted) | 2.39 | 2.57 | 2.54 | 2.42 | 1.63 |
| Gross Profit | 16.57B | 16.81B | 16.05B | 15.59B | 12.28B |
| Operating Income | 3.23B | 3.45B | 3.18B | 3.26B | 2.31B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 63.87B | 64.26B | 60.52B | 60.56B | 59.42B |
| Total Liabilities | 24.39B | 23.26B | 21.63B | 22.41B | 23.54B |
| Shareholders' Equity | 38.87B | 40.38B | 38.24B | 37.46B | 35.06B |
| Total Debt | 17.04B | 13.22B | 11.66B | 12.20B | 13.02B |
| Cash & Equivalents | 3.54B | 2.25B | 2.56B | 1.76B | 1.59B |
| Current Assets | 12.00B | 10.04B | 9.72B | 8.64B | 9.28B |
| Current Liabilities | 12.15B | 10.56B | 9.74B | 8.89B | 8.93B |